14-58270425-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002788.4(PSMA3):c.598A>G(p.Ile200Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,613,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I200T) has been classified as Uncertain significance.
Frequency
Consequence
NM_002788.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSMA3 | NM_002788.4 | c.598A>G | p.Ile200Val | missense_variant | 9/11 | ENST00000216455.9 | |
PSMA3-AS1 | NR_029435.1 | n.414-3032T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSMA3 | ENST00000216455.9 | c.598A>G | p.Ile200Val | missense_variant | 9/11 | 1 | NM_002788.4 | P4 | |
PSMA3-AS1 | ENST00000554360.5 | n.447-3032T>C | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251046Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135710
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461106Hom.: 0 Cov.: 30 AF XY: 0.000166 AC XY: 121AN XY: 726876
GnomAD4 genome AF: 0.000361 AC: 55AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.598A>G (p.I200V) alteration is located in exon 9 (coding exon 9) of the PSMA3 gene. This alteration results from a A to G substitution at nucleotide position 598, causing the isoleucine (I) at amino acid position 200 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 200 of the PSMA3 protein (p.Ile200Val). This variant is present in population databases (rs200984115, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PSMA3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1443450). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at